Cargando…
GW8510 Increases Insulin Expression in Pancreatic Alpha Cells through Activation of p53 Transcriptional Activity
BACKGROUND: Expression of insulin in terminally differentiated non-beta cell types in the pancreas could be important to treating type-1 diabetes. Previous findings led us to hypothesize involvement of kinase inhibition in induction of insulin expression in pancreatic alpha cells. METHODOLOGY/PRINCI...
Autores principales: | Fomina-Yadlin, Dina, Kubicek, Stefan, Vetere, Amedeo, He, Kaihui Hu, Schreiber, Stuart L., Wagner, Bridget K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252286/ https://www.ncbi.nlm.nih.gov/pubmed/22242153 http://dx.doi.org/10.1371/journal.pone.0028808 |
Ejemplares similares
-
Correction: GW8510 Increases Insulin Expression in Pancreatic Alpha Cells through Activation of p53 Transcriptional Activity
por: Fomina-Yadlin, Dina, et al.
Publicado: (2012) -
Quantitative-Proteomic Comparison of Alpha and Beta Cells to Uncover Novel Targets for Lineage Reprogramming
por: Choudhary, Amit, et al.
Publicado: (2014) -
Repositioning of a cyclin-dependent kinase inhibitor GW8510 as a ribonucleotide reductase M2 inhibitor to treat human colorectal cancer
por: Hsieh, Y-Y, et al.
Publicado: (2016) -
Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme
por: Maianti, Juan Pablo, et al.
Publicado: (2019) -
GW Stewart
por: Kilmer, Misha E, et al.
Publicado: (2010)